178 related articles for article (PubMed ID: 19596947)
1. Preoperative leukocytosis, anemia and thrombocytosis are associated with poor survival in non-small cell lung cancer.
Tomita M; Shimizu T; Hara M; Ayabe T; Onitsuka T
Anticancer Res; 2009 Jul; 29(7):2687-90. PubMed ID: 19596947
[TBL] [Abstract][Full Text] [Related]
2. Prognostic impact of thrombocytosis in resectable non-small cell lung cancer.
Tomita M; Shimizu T; Hara M; Ayabe T; Onitsuka T
Interact Cardiovasc Thorac Surg; 2008 Aug; 7(4):613-5. PubMed ID: 18502783
[TBL] [Abstract][Full Text] [Related]
3. Impact of preoperative hemoglobin level on survival of non-small cell lung cancer patients.
Tomita M; Shimizu T; Hara M; Ayabe T; Onitsuka T
Anticancer Res; 2008; 28(3B):1947-50. PubMed ID: 18630486
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors for patients with spinal metastases from lung cancer.
Ogihara S; Seichi A; Hozumi T; Oka H; Ieki R; Nakamura K; Kondoh T
Spine (Phila Pa 1976); 2006 Jun; 31(14):1585-90. PubMed ID: 16778693
[TBL] [Abstract][Full Text] [Related]
5. Preoperative serum C-reactive protein level in non-small cell lung cancer.
Hara M; Matsuzaki Y; Shimuzu T; Tomita M; Ayabe T; Enomoto Y; Onitsuka T
Anticancer Res; 2007; 27(4C):3001-4. PubMed ID: 17695486
[TBL] [Abstract][Full Text] [Related]
6. L-type amino acid transporter 1 expression is a prognostic marker in patients with surgically resected stage I non-small cell lung cancer.
Imai H; Kaira K; Oriuchi N; Yanagitani N; Sunaga N; Ishizuka T; Kanai Y; Endou H; Nakajima T; Mori M
Histopathology; 2009 Jun; 54(7):804-13. PubMed ID: 19635099
[TBL] [Abstract][Full Text] [Related]
7. Thrombocytosis associated with poor prognosis in patients with esophageal carcinoma.
Shimada H; Oohira G; Okazumi S; Matsubara H; Nabeya Y; Hayashi H; Takeda A; Gunji Y; Ochiai T
J Am Coll Surg; 2004 May; 198(5):737-41. PubMed ID: 15110807
[TBL] [Abstract][Full Text] [Related]
8. Impact of interstitial lung disease on survival for patients with non-small cell lung cancer.
Miyazaki K; Satoh H; Kurishima K; Nakamura R; Ishikawa H; Kagohashi K; Ohara G; Hizawa N
Anticancer Res; 2009 Jul; 29(7):2671-4. PubMed ID: 19596944
[TBL] [Abstract][Full Text] [Related]
9. Three immunomarker support vector machines-based prognostic classifiers for stage IB non-small-cell lung cancer.
Zhu ZH; Sun BY; Ma Y; Shao JY; Long H; Zhang X; Fu JH; Zhang LJ; Su XD; Wu QL; Ling P; Chen M; Xie ZM; Hu Y; Rong TH
J Clin Oncol; 2009 Mar; 27(7):1091-9. PubMed ID: 19188679
[TBL] [Abstract][Full Text] [Related]
10. Preoperative anemia, leukocytosis and thrombocytosis identify aggressive endometrial carcinomas.
Njølstad TS; Engerud H; Werner HM; Salvesen HB; Trovik J
Gynecol Oncol; 2013 Nov; 131(2):410-5. PubMed ID: 24004646
[TBL] [Abstract][Full Text] [Related]
11. Tumor-related leucocytosis and chemotherapy-induced neutropenia: linked or independent prognostic factors for advanced non-small cell lung cancer?
Maione P; Rossi A; Di Maio M; Gridelli C
Lung Cancer; 2009 Oct; 66(1):8-14. PubMed ID: 19328587
[TBL] [Abstract][Full Text] [Related]
12. Long-term surgical outcome in patients with lung cancer and coexisting severe COPD.
Nakajima T; Sekine Y; Yamada Y; Suzuki H; Yasufuku K; Yoshida S; Suzuki M; Shibuya K; Fujisawa T; Yoshino I
Thorac Cardiovasc Surg; 2009 Sep; 57(6):339-42. PubMed ID: 19707975
[TBL] [Abstract][Full Text] [Related]
13. [Paraneoplastic Leukocytosis and Thrombocytosis as Prognostic Biomarkers in Non-small Cell Lung Cancer].
Boddu P; Villlines D; Aklilu M
Zhongguo Fei Ai Za Zhi; 2016 Nov; 19(11):725-730. PubMed ID: 27866514
[TBL] [Abstract][Full Text] [Related]
14. Thrombocytosis has a negative prognostic value in lung cancer.
Maráz A; Furák J; Varga Z; Kahán Z; Tiszlavicz L; Hideghéty K
Anticancer Res; 2013 Apr; 33(4):1725-9. PubMed ID: 23564823
[TBL] [Abstract][Full Text] [Related]
15. Hypercalcemia-leukocytosis syndrome associated with lung cancer.
Hiraki A; Ueoka H; Takata I; Gemba K; Bessho A; Segawa Y; Kiura K; Eguchi K; Yoneda T; Tanimoto M; Harada M
Lung Cancer; 2004 Mar; 43(3):301-7. PubMed ID: 15165088
[TBL] [Abstract][Full Text] [Related]
16. Survival and risk factors of surgically treated mediastinal invasion T4 non-small cell lung cancer.
Yang HX; Hou X; Lin P; Rong TH; Yang H; Fu JH
Ann Thorac Surg; 2009 Aug; 88(2):372-8. PubMed ID: 19632375
[TBL] [Abstract][Full Text] [Related]
17. Serum thrombopoietin levels in patients with reactive thrombocytosis due to lung cancer and in patients with essential thrombocythemia.
Werynska B; Ramlau R; Podolak-Dawidziak M; Jankowska R; Prajs I; Usnarska-Zubkiewicz L; Kuliczkowski K
Neoplasma; 2003; 50(6):447-51. PubMed ID: 14689068
[TBL] [Abstract][Full Text] [Related]
18. [The prognostic value of thrombocytosis in patients with primary lung cancer].
Pedersen LM; Milman N
Ugeskr Laeger; 1998 Jun; 160(26):3917-20. PubMed ID: 9656833
[TBL] [Abstract][Full Text] [Related]
19. Polymorphisms in the CASPASE genes and survival in patients with early-stage non-small-cell lung cancer.
Yoo SS; Choi JE; Lee WK; Choi YY; Kam S; Kim MJ; Jeon HS; Lee EB; Kim DS; Lee MH; Kim IS; Jheon S; Park JY
J Clin Oncol; 2009 Dec; 27(34):5823-9. PubMed ID: 19826114
[TBL] [Abstract][Full Text] [Related]
20. Survival among patients with platinum resistant, locally advanced non-small cell lung cancer treated with platinum-based systemic therapy.
d'Amato TA; Pettiford BL; Schuchert MJ; Parker R; Ricketts WA; Luketich JD; Landreneau RJ
Ann Surg Oncol; 2009 Oct; 16(10):2848-55. PubMed ID: 19609620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]